Riskpilot← Back to searchSign inGet full accessNEMUS ULLEVAAL STADION AS
ASActiveOrg 918357467Sognsveien 75B, 0855 OsloTraditional, complementary and alternative medicine activities · NACE 8696Est. 20175 employees
Revenue 2025
NOK 10,8M
+3% vs 2024
EBITDA margin
1.9%
+19% vs 2024
Equity ratio
-9.2%
Financial strength
Net profit 2025
NOK 51K
+827% vs 2024
| Revenue | NOK 10,8M | +3% |
| EBITDA | NOK 204K | +19% |
| Net profit | NOK 51K | +827% |
| Total assets | NOK 2,4M | -9% |
| Equity | NOK -222K | +19% |
| Employees | 5 | — |
Legal name
NEMUS ULLEVAAL STADION AS
Org number
918357467
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
12. januar 2017
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drift av kiropraktikerklinikk, herunder aksjer og verdipapirer samt alt som faller naturlig sammen med dette inkludert deltakelse i andre selskaper.
Address
Sognsveien 75B, 0855 Oslo
Phone
+4722950890
Email
ullevaal@nemus.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 724 | 8 619 | 9 409 | 10 421 | 10 762 |
| Staff expenses | −4 063 | −4 345 | −4 637 | −4 290 | −3 676 |
| EBITDA | 277 | −201 | −210 | 171 | 204 |
| Depreciation & amort. | −9 | −43 | −43 | −43 | −43 |
| EBIT | 268 | −243 | −253 | 128 | 161 |
| Net financials | −14 | −60 | −91 | −115 | −93 |
| Profit before tax | 255 | −304 | −343 | 13 | 68 |
| Tax | 61 | −67 | −71 | 8 | 17 |
| Net profit | 193 | −236 | −272 | 5 | 51 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 300 | 1 865 | 2 412 | 2 649 | 2 405 |
| Equity | 230 | −6 | −278 | −273 | −222 |
| Long-term debt | 983 | 911 | 1 355 | 1 247 | 1 140 |
| Short-term debt | 1 087 | 961 | 1 335 | 1 674 | 1 487 |
| Total debt | 2 070 | 1 871 | 2 690 | 2 922 | 2 627 |
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
20212025
Equity ratio
-9.2%
This company
38.2%
Market median
-124% vs market
20212025
Return on equity
5054300.0%
This company
18.4%
Market median
+27468922% vs market
20212025
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
20212025
Asset turnover
4.48×
This company
1.12×
Market median
+300% vs market
20212025
Debt / equity
11.82×
This company
0.62×
Market median
-1806% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2025 | |
| Chairman | 2017 | |
| Board of Directors | 2025 | |
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 34% | 34% | 2024 | |
| Company | 33% | 33% | 2024 | |
| Company | 33% | 33% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Waliko As
NEMUS ULLEVAAL STADION AS Board members of NEMUS ULLEVAAL STADION AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Magnus Lagerkvist | Chairman | 0 companies |
| Kasper Vincent Myhrvold | Chairman | 0 companies |
| Mats Karl Johan Gunnarsson | Board of Directors | 0 companies |
| Magnus Prener Holtan | Board of Directors | 0 companies |
| Jeppe Birkelid | Board of Directors | 0 companies |